Prestige Consumer Healthcare (PBH) Profit After Tax (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Profit After Tax of $1.4 million for Q4 2025, down 97.76% year-over-year from $61.0 million in Q4 2024, and down 96.81% quarter-over-quarter from $42.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Profit After Tax (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Profit After Tax history runs 16 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- In Q4 2025, Profit After Tax fell 97.76% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $96.6 million (down 55.24% YoY), while the FY2025 annual figure was $211.4 million, up 2.44% from the prior year.
- Profit After Tax for Q4 2025 stood at $1.4 million, down from $42.9 million in the prior quarter.
- The five-year high for Profit After Tax was $162.1 million in Q1 2021, with the low at -$7.1 million in Q3 2022.
- The 5-year median for Profit After Tax is $46.7 million (2024), against an average of $36.4 million.
- The sharpest annual moves came in 2021 and 2022: Profit After Tax sank 178.43% in 2021, then surged 5786.42% in 2022.
- Prestige Consumer Healthcare's Profit After Tax stood at $50.2 million in 2021, then grew by 3.46% to $52.0 million in 2022, then tumbled by 85.63% to $7.5 million in 2023, then soared by 717.58% to $61.0 million in 2024, then tumbled by 97.76% to $1.4 million in 2025.
- Business Quant data shows PBH's Profit After Tax at $1.4 million in Q4 2025, $42.9 million in Q3 2025, and $5.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 42.87 Mn |
| Jun 30, 2025 | 5.40 Mn |
| Mar 31, 2025 | 46.96 Mn |
| Dec 31, 2024 | 61.03 Mn |
| Sep 30, 2024 | 59.18 Mn |
| Jun 30, 2024 | 49.07 Mn |
| Mar 31, 2024 | 46.53 Mn |
| Dec 31, 2023 | 7.47 Mn |
| Sep 30, 2023 | -3.78 Mn |
| Jun 30, 2023 | 52.63 Mn |
| Mar 31, 2023 | -2.08 Mn |
| Dec 31, 2022 | 51.95 Mn |
| Sep 30, 2022 | -7.12 Mn |
| Jun 30, 2022 | 55.27 Mn |
| Mar 31, 2022 | 52.86 Mn |
| Dec 31, 2021 | 50.22 Mn |
| Sep 30, 2021 | -3.65 Mn |
| Jun 30, 2021 | -972,000.00 |
| Mar 31, 2021 | 162.11 Mn |